# Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia

> **NCT00319878** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Office of Rare Diseases (ORD)** · enrollment: 52 (estimated)

## Conditions studied

- Anemia, Aplastic

## Interventions

- **DRUG:** Sirolimus
- **DRUG:** Cyclosporine

## Key facts

- **NCT ID:** NCT00319878
- **Lead sponsor:** Office of Rare Diseases (ORD)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-05
- **Primary completion:** 2009-07
- **Final completion:** 2009-12
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2008-10-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00319878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00319878, "Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00319878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*